Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson reiterates a Buy rating on Hologic (NASDAQ:HOLX) and maintains a $90 price target.
April 10, 2024 | 9:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson reaffirmed a Buy rating on Hologic, with a price target of $90.
The reiteration of a Buy rating and maintenance of a $90 price target by a reputable analyst like Mike Matson could instill confidence among investors and potentially drive Hologic's stock price upwards in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100